FEIBA: A Prohemostatic Agent

Caroline Cromwell(Icahn School of Medicine at Mount Sinai), Louis M. Aledort(Icahn School of Medicine at Mount Sinai)

Seminars in Thrombosis and Hemostasis

March 29, 2012

10.1055/s-0032-1309286

Cited by 19

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

|The Lancet|2008|862

Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

|PubMed|2001|803

Definitions in Hemophilia

|Thrombosis and Haemostasis|2001|772

A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs

|Journal of Internal Medicine|1994|613

A More Uniform Measurement of Factor VIII Inhibitors

|Thrombosis and Haemostasis|1975|587